Abstract
| Original language | English |
|---|---|
| Pages (from-to) | 1243 - 1248 |
| Number of pages | 6 |
| Journal | Digestive and Liver Disease |
| Volume | 48 |
| Issue number | 10 |
| DOIs | |
| Publication status | Published - Oct 1 2016 |
Fingerprint
Keywords
- ERAS
- Fast track
- Hepatocellular carcinoma
- Laparoscopy
- Liver failure
- Liver surgery
ASJC Scopus subject areas
- Hepatology
- Gastroenterology
Cite this
Impact of ERAS approach and minimally-invasive techniques on outcome of patients undergoing liver surgery for hepatocellular carcinoma. / Ratti, Francesca; Cipriani, Federica; Reineke, Raffaella; Catena, Marco; Comotti, Laura; Beretta, Luigi; Aldrighetti, Luca.
In: Digestive and Liver Disease, Vol. 48, No. 10, 01.10.2016, p. 1243 - 1248.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Impact of ERAS approach and minimally-invasive techniques on outcome of patients undergoing liver surgery for hepatocellular carcinoma
AU - Ratti, Francesca
AU - Cipriani, Federica
AU - Reineke, Raffaella
AU - Catena, Marco
AU - Comotti, Laura
AU - Beretta, Luigi
AU - Aldrighetti, Luca
PY - 2016/10/1
Y1 - 2016/10/1
N2 - Background and aim Aim of the study was to assess the impact of ERAS approach (“fluid restrictive and drainless”) on open liver resections for HCC comparing their outcome with open resections in pre-ERAS period and with laparoscopic surgery. Study design 207 patients undergoing minor liver resection for HCC were divided into three groups: Group A, open minor resections in pre-ERAS period (95 patients); Group B, laparoscopic ERAS resections (55 patients); Group C, open ERAS resections (57 patients). Results Blood loss was lower in group C and B compared with group A. Postoperative morbidity was 26.5% in group A, 16.3% in group B and 12.1% in group C (p <0.05). Ascites was less frequent in group B (7.5%) and C (6.2%) compared with group A (12%). Median time for functional recovery in group B (3 days) and C (3 days) was shorter compared with group A (5 days). Conclusions Laparoscopic approach confirms to be associated with reduced blood loss and postoperative morbidity. In patients who cannot be candidates to minimally-invasive approach, ERAS management seems to allow blood loss and postoperative morbidity reduction: indeed, results achieved in this group of patients are more similar to those of laparoscopy than to pre-ERAS open surgery.
AB - Background and aim Aim of the study was to assess the impact of ERAS approach (“fluid restrictive and drainless”) on open liver resections for HCC comparing their outcome with open resections in pre-ERAS period and with laparoscopic surgery. Study design 207 patients undergoing minor liver resection for HCC were divided into three groups: Group A, open minor resections in pre-ERAS period (95 patients); Group B, laparoscopic ERAS resections (55 patients); Group C, open ERAS resections (57 patients). Results Blood loss was lower in group C and B compared with group A. Postoperative morbidity was 26.5% in group A, 16.3% in group B and 12.1% in group C (p <0.05). Ascites was less frequent in group B (7.5%) and C (6.2%) compared with group A (12%). Median time for functional recovery in group B (3 days) and C (3 days) was shorter compared with group A (5 days). Conclusions Laparoscopic approach confirms to be associated with reduced blood loss and postoperative morbidity. In patients who cannot be candidates to minimally-invasive approach, ERAS management seems to allow blood loss and postoperative morbidity reduction: indeed, results achieved in this group of patients are more similar to those of laparoscopy than to pre-ERAS open surgery.
KW - ERAS
KW - Fast track
KW - Hepatocellular carcinoma
KW - Laparoscopy
KW - Liver failure
KW - Liver surgery
UR - http://www.scopus.com/inward/record.url?scp=84981744776&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84981744776&partnerID=8YFLogxK
U2 - 10.1016/j.dld.2016.06.032
DO - 10.1016/j.dld.2016.06.032
M3 - Article
VL - 48
SP - 1243
EP - 1248
JO - Digestive and Liver Disease
JF - Digestive and Liver Disease
SN - 1590-8658
IS - 10
ER -